- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01909076
Transforming Opioid Prescribing in Primary Care (TOPCARE)
Implementing Opioid Risk Reduction Strategies Into Primary Care Practice
Prescription opioid misuse is a significant public health problem as well as a patient safety concern. Primary care providers are the leading prescribers of opioids for chronic pain, yet few providers follow standard practice guidelines regarding assessment and monitoring. The investigators propose a novel system change in delivery of primary care services to decrease misuse of and addiction to prescription opioids for patients with chronic pain.
The proposed intervention for the overall project includes a nurse-managed registry for planning individual patient care and conducting population-based care for a population of patients receiving opioids for chronic pain. Academic detailing to clinicians is another effective way to improve care. Finally, the researchers will create a knowledge management tool to facilitate guideline adherence. This tool will be accessible via an internet link, and will include validated instruments to assess patient status and also to facilitate physician adherence to suggested monitoring.
Study Overview
Status
Conditions
Detailed Description
This project will implement interventions in the primary care setting to improve management of patients prescribed opioid therapy for chronic non-cancer pain.
Prescription opioid misuse is a significant current public health problem as well as a patient safety concern. Primary care providers are the leading prescribers of opioids for chronic pain, yet few providers follow standard practice guidelines regarding assessment and monitoring. The investigators propose a novel system change in delivery of primary care services to decrease misuse of and addiction to prescription opioids for patients with chronic pain.
The researchers will conduct a cluster randomized controlled trial, randomizing 50 primary care providers and their estimated 500 patients to the intervention condition (nurse care management, registry, electronic decision support tools, and academic detailing) or control condition (electronic decision support tools and educational outreach only). The primary outcomes, measured at twelve months, are PCP adherence to chronic opioid therapy guidelines and opioid misuse.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All PCPs (physicians, doctors of osteopathy, nurse practitioners, and physicians' assistants) at participating sites with 4 patients prescribed opioid treatment along with their patients greater than or equal to age 18 who have 1) 3 or more completed visits to the primary care practice; 2) long-term opioid treatment defined by 3 or more opioid prescriptions written at least 21 days apart within 6 months; and 3) an inpatient or outpatient ICD9CM diagnosis for musculoskeletal or neuropathic pain. In addition, non-PCP staff at the health centers and at the Massachusetts State PMP who agree to be included in the qualitative assessments will be included and will be considered subjects. Note that the investigators have limited inclusion in the study to PCPs with at least 4 patients on chronic opioid therapy because it was determined that for PCPs with fewer than 4 patients the time burden associated with the study (meeting with nurse care manager, receiving academic detailing etc) would not be justified.
Exclusion Criteria:
- Patients currently receiving care for cancer, except non-melanoma skin cancer. Patients with remote (>5 years) histories being disease-free from other cancers (e.g. breast, colon, prostate) will not be excluded due to the low risk of current cancer related pain. PCPs and staff who do not consent to the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control PCPs and their patients
PCPs randomized to the control condition will receive electronic decision support tools.
Patients of control PCPs will receive education materials that will be developed and made available to both control and intervention patients.
|
Electronic decision support tools available to both control and intervention PCPs include patient pain assessments, (Brief Pain Inventory, Pain/Enjoyment/General Function "PEG"), substance abuse (DAST, AUDIT) depression (PHQ9), PTSD (PTSD ChecklistCivilian), and risk of prescription drug misuse (SOAPP and COMM).
The tools calculate scores with recommendation for specific action for each tool, when appropriate.
Patient education materials will be developed and made available to both control and intervention patients.
The investigators will design the materials for patients with low literacy, using pictures and simple graphics to augment written language.
The research staff will make PDFs of the materials available on the study website during and after the project.
|
Experimental: Intervention PCPs and patients
The Intervention Condition has three main components: access to nurse care management, access to the patient registry, and academic detailing for intervention PCPs.
Intervention PCPs will also receive the control intervention of electronic decision support tools, and patients of intervention PCPs will receive the same patient education materials as patients of control PCPs.
|
Electronic decision support tools available to both control and intervention PCPs include patient pain assessments, (Brief Pain Inventory, Pain/Enjoyment/General Function "PEG"), substance abuse (DAST, AUDIT) depression (PHQ9), PTSD (PTSD ChecklistCivilian), and risk of prescription drug misuse (SOAPP and COMM).
The tools calculate scores with recommendation for specific action for each tool, when appropriate.
Patient education materials will be developed and made available to both control and intervention patients.
The investigators will design the materials for patients with low literacy, using pictures and simple graphics to augment written language.
The research staff will make PDFs of the materials available on the study website during and after the project.
The nurse/care management intervention will be modeled on BMC's successful collaborative care office-based opioid treatment (OBOT) program.
One fulltime nurse care manager will work with PCPs assigned to the intervention condition.
The care manager will be based centrally, in the Section of General Internal Medicine, and will divide his/her time between the 3 health centers.
The main focus of the nurse care manager is to assure that patients are receiving guideline-adherent care, which involves appropriate clinical assessments, opioid treatment agreements, refill management, administering monitoring tools according to risk level (urine toxicology screen, pill counts, PMP data extraction) and timely physician visits to assess pain (minimum every 6 months).
The registry will be a freestanding centralized disease management application and built using standard database technology.
This system will communicate with the electronic medical record (EMR) at each community health center and with the Massachusetts State Prescription Monitoring Program (PMP) system.
Data that will feed into the registry include clinical data recorded from the EMR (documentation from other clinicians and labs), data from clinical users entered into the registry via pain and opioid management forms, and the PMP.
The nurse care manager will use a custom registry interface to monitor key practice activities across the entire practice at each site.
The nurse care manager will use population management tools to provide aggregate measures for quality monitoring and workforce management.
All quality metrics can be downloaded in aggregate form for further analysis.
All PCPs in the intervention group will receive one 30 minute individual visit 23 months after project implementation at the PCP's practice site.
The visits will be conducted with at least one of the study experts in pain medication management.
Visit content will combine elements of audit and feedback (e.g.
review registry of individual PCP compared with that of peers and goals) as well as traditional educational outreach.
Specifically, experts will review each aspect of guideline concordant care (assessment of risk and appropriateness for opioid medication, medication dosing, monitoring for harm/adherence, and pain outcomes) to solicit barriers to implementation or lack of knowledge on the underlying evidence for each aspect of care.
The experts will work with the individual PCPs to address barriers identified using motivational interviewing as needed to facilitate behavioral change in applying guideline concordant care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PCP adherence to chronic opioid therapy guidelines
Time Frame: up to 12 months.
|
The primary outcomes is PCP adherence to chronic opioid therapy guidelines and is defined as whether a PCP's patient has
|
up to 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient opioid misuse, as measured by number of early refills
Time Frame: Each PCP's patient list will be assessed at baseline and at 12 months.
|
The secondary outcome measures patient opioid misuse, defined as having multiple (>2) early refills in the past year.
To identify early refills of opioid prescriptions, the researchers will calculate the duration of a prescription based on the number dispensed and the directions, conservatively assuming that the patient took the medication at the maximal prescribed rate.
The investigators define an early refill as being written at least 7 days before the previous prescription for the same medication should have been finished.
|
Each PCP's patient list will be assessed at baseline and at 12 months.
|
Patient opioid and illicit substance misuse and/or abuse, as measured by urine toxicology results
Time Frame: Each PCP's patient list will be assessed at baseline and at 12 months.
|
Patient substance abuse will be measured as urine drug tests where an illicit substance is present, the prescribed opioid is absent, and/or the patient has missed the urine drug screen.
|
Each PCP's patient list will be assessed at baseline and at 12 months.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Karen Lasser, MD, MPH, Boston Medical Center
- Principal Investigator: Jane E Liebschutz, MD, MPH, Boston Medical Center
Publications and helpful links
General Publications
- Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, Guara G, O'Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial. JAMA Intern Med. 2017 Sep 1;177(9):1265-1272. doi: 10.1001/jamainternmed.2017.2468.
- Lasser KE, Shanahan C, Parker V, Beers D, Xuan Z, Heymann O, Lange A, Liebschutz JM. A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol. J Subst Abuse Treat. 2016 Jan;60:101-9. doi: 10.1016/j.jsat.2015.06.018. Epub 2015 Jul 15.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01DA034252-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Vastra Gotaland RegionCompletedPain, Chronic | Widespread Chronic PainSweden
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Societa Italiana Anestesia Analgesia Rianimazione...RecruitingPost Operative Pain | Postoperative Pain, Chronic | Post Surgical PainItaly
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
University Health Network, TorontoAcademic Medical Organization of Southwestern Ontario; York University; Toronto...Not yet recruitingPain, Acute | Pain, Chronic | Post-surgical Pain | Post-Surgical Pain, ChronicCanada
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
Clinical Trials on Electronic decision support tools
-
Seattle Children's HospitalAmerican Academy of PediatricsCompletedFluid and Electrolyte Imbalance | Intravenous Fluids | ADH InappropriateUnited States
-
Brigham and Women's HospitalHarvard Vanguard Medical AssociatesCompletedChronic Kidney DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedPsychotic Disorders | Tobacco Smoking | Mental IllnessUnited States
-
Brittany LapinLearning Health Systems Rehabilitation Research NetworkRecruitingPhysical Therapy EvaluationUnited States
-
St Elizabeth HealthcarePATH Decision Support Software, LLCCompletedDiabetes MellitusUnited States
-
University of AarhusDanish Cancer Society; TrygFonden, DenmarkWithdrawnChronic Obstructive Pulmonary Disease | Metastatic CancerDenmark
-
South London and Maudsley NHS Foundation TrustActive, not recruitingStroke | Atrial FibrillationUnited Kingdom
-
Agency for Healthcare Research and Quality (AHRQ)Children's Hospital of PhiladelphiaCompleted
-
McMaster UniversityHealth CanadaCompleted
-
Kaiser PermanenteCompletedPulmonary EmbolismUnited States